LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Annatto Component Prevents UV Damage and Prevents Skin Cancer in Mouse Model

By LabMedica International staff writers
Posted on 09 Feb 2016
Image: Open fruit of the achiote tree (Bixa orellana), showing the seeds from which annatto is extracted (Photo courtesy of Wikimedia Commons).
Image: Open fruit of the achiote tree (Bixa orellana), showing the seeds from which annatto is extracted (Photo courtesy of Wikimedia Commons).
The apocarotenoid compound bixin is a widely consumed food additive that was shown in a recent paper to have potent antioxidant properties, which prevented the formation of cancer cells and skin damage from UV radiation in a mouse model.

Apocarotenoids are organic compounds derived from carotenoids by oxidative cleavage, catalyzed by carotenoid oxygenases. Examples include the vitamin A retinoids retinal, retinoic acid, and retinol; and the plant hormone abscisic acid.

Investigators at the University of Arizona (Tucson, USA) based their research on recent studies that suggested a photoprotective role of gene expression in skin cells orchestrated by the transcription factor Nrf2 (nuclear factor-E2-related factor 2). They explored the molecular mechanism underlying carotenoid-based systemic skin photoprotection in the SKH-1 mouse model.

A group of SKH-1 mice were injected with bixin, a [US] Food and Drug Administration approved compound found in annatto. Annatto is an orange-red condiment and food coloring derived from the seeds of the achiote tree (Bixa orellana). It is often used to impart a yellow or orange color to foods, but sometimes also for its flavor and aroma. The color of annatto comes from various carotenoid pigments, mainly bixin and norbixin, found in the reddish waxy coating of the seeds. Annatto and its extracts are now widely used as a coloring agent in many processed food products.

Results published in the November 4, 2015, online edition of the journal Free Radical Biology and Medicine revealed that systemic administration of bixin suppressed skin photodamage by suppressing epidermal oxidative DNA damage and inflammatory responses in the mice.

The investigators found that bixin activated Nrf2 through the critical cysteine-151 sensor residue in Keap1 (Kelch-like ECH-associated protein 1). Under quiescent conditions, Nrf2 is anchored in the cytoplasm through binding to Keap1, which, in turn, facilitates the ubiquitination and subsequent proteolysis of Nrf2. Because Nrf2 activation leads to a coordinated antioxidant and anti-inflammatory response, and Keap1 represses Nrf2 activation, Keap1 has become a very attractive drug target.

DNA damage and inflammatory responses were suppressed in mice carrying the NRF2 gene but not in mice that lacked the gene, confirming the NRF2-dependence of bixin-based photoprotection.

Senior author Dr. Georg Wondrak, associate professor of pharmacology and toxicology at the University of Arizona, said, "This discovery is unique because bixin is a nutritional factor, not a sunscreen applied to the skin. It prevents UV skin damage from the inside out by inducing cells to make protective antioxidants and repair factors. The compound does not kill skin cancer cells, but prevents their forming in the first place."

Related Links:

University of Arizona


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Gold Member
Immunochromatographic Assay
CRYPTO Cassette

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more